Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer

Author:

Venook Alan P.1,Niedzwiecki Donna2,Lenz Heinz-Josef3,Innocenti Federico4,Fruth Briant5,Meyerhardt Jeffrey A.6,Schrag Deborah6,Greene Claire1,O'Neil Bert H.7,Atkins James Norman8,Berry Scott9,Polite Blase N.10,O'Reilly Eileen M.11,Goldberg Richard M.12,Hochster Howard S.13,Schilsky Richard L.14,Bertagnolli Monica M.15,El-Khoueiry Anthony B.3,Watson Peter16,Benson Al B.17,Mulkerin Daniel L.18,Mayer Robert J.6,Blanke Charles19

Affiliation:

1. University of California, San Francisco

2. Department of Biostatistics and Bioinformatics and Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina

3. University of Southern California, Los Angeles

4. University of North Carolina at Chapel Hill

5. Alliance Statistics and Data Center, Mayo Clinic Cancer Center, Rochester, Minnesota

6. Dana-Farber/Partners CancerCare, Boston, Massachusetts

7. Indiana University, Simon Cancer Center, Indianapolis

8. National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, and Southeastern Medical Oncology Center, Goldsboro, North Carolina

9. Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada

10. University of Chicago Comprehensive Cancer Center, Chicago, Illinois

11. Memorial Sloan Kettering Cancer Center, New York, New York

12. Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital, Columbus

13. Department of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut

14. American Society of Clinical Oncology, Alexandria, Virginia

15. Brigham and Women's Hospital, Boston, Massachusetts

16. Lenoir Memorial Hospital/Kinston Medical Specialists PA, Kinston, North Carolina

17. Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois

18. University of Wisconsin, Madison

19. Southwest Oncology Group Chair’s Office and Knight Cancer Institute, Oregon Health & Science University, Portland

Publisher

American Medical Association (AMA)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3